These T-lymphocytes were predominantly CD8+ cytotoxic lymphocytes, whereas CD4+ T-lymphocytes were scarce in the adenocarcinoma, and lymph node metastases, were mainly absent in the bulky tumor. The gene discussed is CD8A; the disease is neoplasm.